Literature DB >> 23550648

The emerging role of microRNAs in regulating immune and inflammatory responses in the lung.

Paul S Foster1, Maximilian Plank, Adam Collison, Hock L Tay, Gerard E Kaiko, Jingjing Li, Sebastian L Johnston, Philip M Hansbro, Rakesh K Kumar, Ming Yang, Joerg Mattes.   

Abstract

Chronic inflammatory diseases of the lung are leading causes of morbidity and mortality worldwide. Many of these disorders can be attributed to abnormal immune responses to environmental stimuli and infections. As such, understanding the innate host defense pathways and their regulatory systems will be critical to developing new approaches to treatment. In this regard, there is increasing interest in the role of microRNAs (miRNAs) in the regulation of pulmonary innate host defense responses and the inflammatory sequelae in respiratory disease. In this review, we discuss recent findings that indicate an important role for miRNAs in the regulation in mouse models of various respiratory diseases and in host defense against bacterial and viral infection. We also discuss the potential utility and limitations of targeting these molecules as anti-inflammatory strategies and also as a means to improve pathogen clearance from the lung.
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23550648     DOI: 10.1111/imr.12058

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  47 in total

1.  MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD.

Authors:  Alan C-Y Hsu; Kamal Dua; Malcolm R Starkey; Tatt-Jhong Haw; Prema M Nair; Kristy Nichol; Nathan Zammit; Shane T Grey; Katherine J Baines; Paul S Foster; Philip M Hansbro; Peter A Wark
Journal:  JCI Insight       Date:  2017-04-06

2.  Modulation of miRNA-155 alters manganese nanoparticle-induced inflammatory response.

Authors:  Matthew W Grogg; Laura K Braydich-Stolle; Elizabeth I Maurer-Gardner; Natasha T Hill; Suraj Sakaram; Madhavi P Kadakia; Saber M Hussain
Journal:  Toxicol Res (Camb)       Date:  2016-10-13       Impact factor: 3.524

3.  Temporal Changes in Microrna Expression in Blood Leukocytes from Patients with the Acute Respiratory Distress Syndrome.

Authors:  Purushottam Narute; Nitin Seam; Margaret Tropea; Carolea Logun; Rongman Cai; Junfeng Sun; James H Shelhamer; Gianfranco U Meduri; Anthony F Suffredini
Journal:  Shock       Date:  2017-06       Impact factor: 3.454

4.  Clinical efficacy of implementing Bio Immune(G)ene MEDicine in the treatment of chronic asthma with the objective of reducing or removing effectively corticosteroid therapy: A novel approach and promising results.

Authors:  Gilbert Glady
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

Review 5.  Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma.

Authors:  Paul S Foster; Steven Maltby; Helene F Rosenberg; Hock L Tay; Simon P Hogan; Adam M Collison; Ming Yang; Gerard E Kaiko; Philip M Hansbro; Rakesh K Kumar; Joerg Mattes
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

Review 6.  Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators.

Authors:  Madhur D Shastri; Wai Chin Chong; Kamal Dua; Gregory M Peterson; Rahul P Patel; Malik Q Mahmood; Murtaza Tambuwala; Dinesh K Chellappan; Nicole G Hansbro; Shakti D Shukla; Philip M Hansbro
Journal:  Inflammopharmacology       Date:  2020-11-05       Impact factor: 4.473

7.  RNA regulation of the immune system.

Authors:  K Mark Ansel
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

8.  RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling.

Authors:  Kohei Hasegawa; Marcos Pérez-Losada; Claire E Hoptay; Samuel Epstein; Jonathan M Mansbach; Stephen J Teach; Pedro A Piedra; Carlos A Camargo; Robert J Freishtat
Journal:  Pediatr Res       Date:  2018-01-17       Impact factor: 3.756

9.  3,39-Diindolylmethane Ameliorates Staphylococcal Enterotoxin B–Induced Acute Lung Injury through Alterations in the Expression of MicroRNA that Target Apoptosis and Cell-Cycle Arrest in Activated T Cells.

Authors:  David M Elliott; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2016-04       Impact factor: 4.030

10.  Chronic cigarette smoke exposure induces systemic hypoxia that drives intestinal dysfunction.

Authors:  Michael Fricker; Bridie J Goggins; Sean Mateer; Bernadette Jones; Richard Y Kim; Shaan L Gellatly; Andrew G Jarnicki; Nicholas Powell; Brian G Oliver; Graham Radford-Smith; Nicholas J Talley; Marjorie M Walker; Simon Keely; Philip M Hansbro
Journal:  JCI Insight       Date:  2018-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.